| Teva |
T-1636-08 |
2008-10-23 |
0 |
2010-07-29 |
21.25 |
- Application was heard on 2010-03-22.
- Application with respect to the formulation patent (’783) was dismissed on 2010-03-25.
|
| Apotex |
T-1972-08 |
2008-12-22 |
2 |
2010-07-29 |
19.25 |
- Apotex requested a hearing adjacent to Teva’s.
- Application was heard on 2010-03-29, on the heels of Teva’s hearing.
- No dismissal decision on any patent.
|
| Cobalt |
T-780-09 |
2009-05-14 |
6.75 |
2010-12-06 |
18.75 |
- Application was set for a hearing on 2010-11-29.
- Application was adjourned without being heard.
|
| Sandoz |
T-1074-09 |
2009-07-02 |
8.25 |
2011-01-27 |
18.75 |
- Application was set for a hearing on 2011-04-11.
- On 2010-04-26, the application with respect to the formulation patent (’783) was dismissed (as a result of Teva’s success).
- Application was adjourned without being heard.
|
| PMS |
T-528-10 |
2010-04-07 |
17.5 |
2012-03-16 |
23.25 |
- Application was heard on 2012-01-09.
- Application was dismissed shortly afterward without a decision being rendered.
|
| Ranbaxy |
T-1367-10
T-1368-10
T-1369-10 |
2010-08-26 |
22 |
2011-09-19 |
12.75 |
- Application in early stages.
- Application stayed shortly after commencement.
|
| Mylan |
T-1535-10 |
2010-09-24 |
23 |
2011-04-19 |
6.75 |
- Application in early stages.
- Application stayed shortly after commencement.
|
| Riva |
T-1249-11
T-1250-11 |
2011-07-29 |
33.25 |
2011-11-09 |
3.25 |
- Shortly after commencement, the application was discontinued on 2011-11-09.
|